BNTX - BioNTech SE

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
Total Revenue
144,380
127,575
61,598
Cost of Revenue
17,400
13,690
9,318
Gross Profit
126,980
113,885
52,280
Operating Expenses
Research Development
212,835
143,040
85,496
Selling General and Administrative
45,273
27,090
29,492
Total Operating Expenses
257,951
167,738
113,276
Operating Income or Loss
-130,971
-53,853
-60,996
Interest Expense
1,707
1,721
676
Total Other Income/Expenses Net
-
5,966
-26,314
Income Before Tax
-122,377
-47,662
-85,905
Income Tax Expense
45
600
45
Income from Continuing Operations
-122,422
-48,262
-85,950
Net Income
-122,185
-48,019
-85,653
Net Income available to common shareholders
-122,185
-48,019
-85,653
Reported EPS
Basic
-
-0.21
-0.38
Diluted
-
-0.21
-0.38
Weighted average shares outstanding
Basic
-
226,262
226,262
Diluted
-
226,262
226,262
EBITDA
-
-23,957
-74,700